NEW PRODUCTS
Cardiovascular Systems Inc., St. Paul, has submitted its premarket approval application to the U.S. Food and Drug Administration for its orbital atherectomy system, used to treat calcified coronary arteries.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT